Comment on Dawed et al. Genome-Wide Meta-Analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682
Diabetes Care
.
2022 Apr 1;45(4):e80-e81.
doi: 10.2337/dc21-2428.
Authors
Ke Wang
1
,
Mai Shi
1
,
Aimin Yang
1
,
Brian Tomlinson
1
2
,
Juliana C N Chan
1
3
4
,
Elaine Chow
1
4
5
Affiliations
1
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
2
Faculty of Medicine, Macau University of Science and Technology, Macau, China.
3
Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
4
Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
5
Phase 1 Clinical Trial Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China.
PMID:
35349650
PMCID:
PMC9016726
DOI:
10.2337/dc21-2428
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Blood Glucose
Diabetes Mellitus*
Humans
Sulfonylurea Compounds* / therapeutic use
Substances
Blood Glucose
Sulfonylurea Compounds